Identifying Drug Targets in Brugia malayi
Author Information
Author(s): Kumar Sanjay, Chaudhary Kshitiz, Foster Jeremy M., Novelli Jacopo F., Zhang Yinhua, Wang Shiliang, Spiro David, Ghedin Elodie, Carlow Clotilde K. S.
Primary Institution: New England Biolabs, Inc.
Hypothesis
Can we use a genome-wide approach to identify essential genes in Brugia malayi for drug target discovery?
Conclusion
The study successfully identified 589 potential drug targets in Brugia malayi using a comparative genomics approach.
Supporting Evidence
- More than 1.5 billion people are at risk of lymphatic filariasis.
- Drug treatments for filariasis have not changed significantly in over 20 years.
- The methodology was endorsed by the World Health Organization as a promising approach.
Takeaway
Researchers found many important genes in a parasite that could help create new medicines to fight diseases caused by it.
Methodology
The study used comparative genomics and RNA interference data from Caenorhabditis elegans to identify essential genes in Brugia malayi.
Potential Biases
Potential bias due to reliance on a model organism (C. elegans) for functional data.
Limitations
The methodology relies on the availability of genomic data and may not account for all functional aspects of the genes.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website